Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9609 posts found.

Astellas abandons oral anticoagulant darexaban

September 30, 2011 Research and Development Astellas, Eliquis, Xarelto, darexaban

Astellas Pharma has abandoned the development of its oral direct factor Xa inhibitor darexaban. The Japanese firm blamed both the …
News

R&D jobs in emerging markets – leaders wanted

September 29, 2011 Business Services, Research and Development Jobs, careers, pharma jobs

The globalisation of pharmaceutical research and development is creating a wave of job opportunities in emerging markets such as India …
Feature

NICE blames pharma R&D model for spiralling cancer drug costs

September 29, 2011 Research and Development, Sales and Marketing Cancer, NICE, clincial trials

NICE has blamed the pharma industry’s ‘inefficient’ and increasingly costly R&D model for the rising price of cancer drugs. NICE …
News

Researchers call for European clinical trial reform

September 28, 2011 Research and Development Euorpe, clinical trials

Medical researchers are calling for regulatory red tape to be snipped away from the legal requirements around clinical trials in …
News

Lilly launches ‘open innovation’ drug discovery

September 28, 2011 Research and Development OIDD, TB, lilly

Lilly has launched a new open innovation platform designed to help build its pipeline and to identify new treatments for …
News

Roche’s Herceptin successor impresses at EMCC

September 27, 2011 Research and Development Herceptin, Roche, TDM-1

Roche’s next-generation breast cancer drug T-DM1 has impressed at the European cancer congress after besting Herceptin in a new study. …
News
Boehringer Ingelheim

Boehringer to create biosimilars division

September 27, 2011 Research and Development Boehringer, biosimilars

Boehringer Ingelheim is to tap into the growing interest in biosimilars with the creation of a division dedicated to that …
News

Healthcare 2025: what the future holds for pharma

September 22, 2011 Manufacturing and Production, Research and Development, Sales and Marketing NHS reform, healthcare reform, healthcare spending, prescribing

We are in the middle of a huge upheaval where everything we know is being turned on its head. Welcome …
Feature

Sanofi spots acne vaccine opportunity

September 22, 2011 Research and Development Sanofi, acne, dermatology

Sanofi Pasteur has signed a new research deal with the University of California, San Diego for its investigational acne vaccine. …
News
President Obama

Obama proposes seven year rule for biologics

September 21, 2011 Research and Development, Sales and Marketing Obama, biologics

President Obama has returned to the issue of market exclusivity for biologic drugs as a way of cutting healthcare costs. …
News

Silence Therapeutics appoints Thomas Christely

September 21, 2011 Research and Development appointment, research and development

UK-headquartered biotech Silence Therapeutics has appointed Thomas Christély as chief executive. He was instrumental in the merger of Silence Therapeutics …
Appointment

Pharmacovigilance Compliance Report submission; MHRA’s Risk Based Compliance Programme

September 20, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PV, Wainwright Associates

A new version of the MHRA pharmacovigilance Compliance Report (Good Pharmacovigilance Practice Questionnaire) has been released by the MHRA.Submission of …
News
Press release

Roche to show new cancer data at European congress

September 20, 2011 Research and Development Cancer, Roche, T-DM1, Zelboraf, avastin

Roche will highlight a range of new approaches in targeting cancer at the upcoming European cancer conference. In a series …
News
Merck Serono

Merck licences new MS drug

September 19, 2011 Research and Development Cladribine, Merck KGaA, Merck Serono, PI-2301

Merck KGaA has in-licensed a new multiple sclerosis drug and aims to start it in phase II studies later this …
News

Melanoma: new treatments and hopes

September 19, 2011 Research and Development advanced melanoma, melanoma, skin cancer

It usually starts with a subtle change of colour or shape in an existing mole. But if left undiagnosed and …
Feature
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026